India's drug regulator is creating new rules for dangerous solvents in children's medicines. This follows tragic deaths linked to contamina...

Many small drug makers face closure as regulators inspect facilities for quality standards. Thousands of plants may shut down if upgrades a...

The Enforcement Directorate (ED) conducted searches at seven locations in Chennai concerning the Coldrif cough syrup case. These raids, und...

Madhya Pradesh police have registered an FIR against Sresan Pharma for allegedly adulterated Coldrif syrup, linked to the deaths of 21 chil...

Lapses by the Tamil Nadu Food and Drug Administration in enforcing basic regulatory norms have been exposed following the deaths of childre...

India's drug regulator is launching nationwide inspections of cough syrup manufacturers following child deaths allegedly linked to toxic sy...

India's drug regulator, CDSCO, initiated risk-based inspections at 19 drug manufacturing units, including cough syrups, across six states f...

Data from the CDSCO reveals that numerous MSME pharmaceutical companies in India are producing substandard drugs, failing to meet safety st...

Drug recalls due to failed quality tests have seen a concerning rise in India, from 950 batches in 2019-20 to a provisional 1,394 in 2023-2...

Talking to ANI, the Gautam Buddha Nagar drug inspector Vaibhav Babbar said "We have suspended the production license of Marion Biotech comp...

The Drugs Controller General of India has initiated a probe in connection with the incident, and Union health minister Mansukh Mandaviya sa...

A committee of two joint drugs controllers has been constituted at the CDSCO headquarters to monitor the process of inspection, reporting a...

Under Section 20 of the RTI Act, if CIC is convinced that information denial was unjustified and arising out of malafide intention, it may ...

According to the proposal, the sites will be inspected if they have made substandard drugs, received quality complaints, or faced action by...

CDSCO has done away with the need for joint inspections to issue licences to allow such companies to make biologic products for testing and...

According to some GMP experts, CDSCO’s proposed move may be different from the risk-based inspection system followed by the US Food and Dru...

The government is contemplating joining a global alliance of pharmaceutical regulators, a move that could help local companies scale up to ...